Anyone selling at this price is definitely desperate or has completely given up. Fortunately, the technology has gotten noticed and it will become a must have to all diagnostic labs and research centers. I believe we will see Recaf become to Biocurex what Ipod has become to Apple. We will be rewarded, but let's make it a sure fire winner with an experienced CEO immediately following the next infusion of cash.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.